DAPSONE
Clinical Indication
Dermatology
Comments
See shared care agreement for details.
Date of classification
April 2024
Orange
Shared Care Agreement. Higher risk medicines requiring significant regular monitoring which would be initiated by or at the recommendation of a specialist service which may include mental health services, secondary care, tertiary care, community providers, private providers and GPs with a specialist interest.